Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
Our high-tech, dedicated method is applied to construct targeted libraries.
Fig. 1. The sreening workflow of Receptor.AI
Utilising molecular simulations, our approach thoroughly examines a wide array of proteins, tracking their conformational changes individually and within complexes. Ensemble virtual screening enables us to address conformational flexibility, revealing essential binding sites at functional regions and allosteric locations. Our rigorous analysis guarantees that no potential mechanism of action is overlooked, aiming to uncover new therapeutic targets and lead compounds across diverse biological functions.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
Q9Y5X1
UPID:
SNX9_HUMAN
Alternative names:
SH3 and PX domain-containing protein 1; SH3 and PX domain-containing protein 3A
Alternative UPACC:
Q9Y5X1; Q9BSI7; Q9BVM1; Q9UJH6; Q9UP20
Background:
Sorting nexin-9, known for its alternative names SH3 and PX domain-containing protein 1 and 3A, plays a pivotal role in cellular processes such as endocytosis, vesicle trafficking, and cytokinesis. It is essential for the normal formation of the cleavage furrow during mitosis, facilitating efficient cell division. Furthermore, it is involved in both clathrin-coated and clathrin-independent, actin-dependent fluid-phase endocytosis, contributing to macropinocytosis and the internalization of TNFR. Its role in promoting the degradation of EGFR post-EGF signaling and stimulating the GTPase activity of DNM1 underscores its significance in cellular signaling pathways.
Therapeutic significance:
Understanding the role of Sorting nexin-9 could open doors to potential therapeutic strategies.